Chemed Corp
NYSE:CHE
Chemed Corp
Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream.
Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.
Chemed Corporation, a somewhat enigmatic yet resolutely steadfast entity, operates in the realms of hospice care and plumbing services, a duality that intrigues analysts and investors alike. Established through strategic foresight, Chemed has crafted a remarkably resilient business model by housing two distinct subsidiaries under its corporate umbrella: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, which still stands as the nation's largest provider of end-of-life care, dominates the hospice sector by offering comprehensive palliative care services right at the patients' doorstep, aiming to ensure dignity and comfort during life's final stages. This subsidiary capitalizes on a combination of Medicare and Medicaid reimbursements as well as private insurances, which form the backbone of its revenue stream.
Meanwhile, Roto-Rooter, a company with a name synonymous with plumbing repair and maintenance, fortifies Chemed's revenue streams through an entirely different channel. Known as a household name across America, Roto-Rooter offers an extensive range of services from emergency plumbing repair to water cleanup and restoration. With its franchise model combined with company-operated branches, Roto-Rooter generates income primarily through service fees. The dual nature of Chemed’s operational style—a blend of healthcare sensitivity and industrial pragmatism—not only ensures diversified income avenues but also exemplifies a pragmatic approach to risk management. This business strategy, deftly combining distinct yet robust sectors, allows Chemed to weather economic fluctuations that might impact one industry but not the other, ultimately creating a stable financial foundation for the company.
Q4 Miss: Chemed’s fourth quarter 2025 results fell short of expectations for both VITAS and Roto-Rooter, with management openly acknowledging a significant miss and discussing the causes.
VITAS Florida Cap Resolved: The Florida Medicare Cap issue, a major headwind in 2025, has been fully addressed, allowing VITAS to rebalance its patient mix for better growth and margins in 2026.
Roto-Rooter Revenue Decline: Roto-Rooter revenue declined 3.7% in Q4, weighed down by a drop in residential revenue and increased write-offs in water restoration.
Guidance for 2026: Both VITAS and Roto-Rooter are expected to see growth resume in 2026, with improvements weighted to the second half of the year; management affirmed confidence in hitting new guidance.
Paid vs. Natural Leads: Roto-Rooter continues to transition from natural (free) to paid leads, with paid leads up 9.4% in Q4 but total leads flat as natural leads declined.
Margin Pressures: Higher hospital-based admissions at VITAS and increased marketing plus write-offs at Roto-Rooter weighed on margins, but actions are in place to improve profitability.
Share Repurchases: Chemed repurchased 400,000 shares in Q4 at an average price of $436.39.
